Aducanumab, Inderbir S. Padda, Mayur S. Parmar
Mayur Parmar

Biosimilars Use in Medicine for Inflammatory Diseases, Inderbir S. Padda, Rajat Bhatt, Obaid Rehman, Mayur S. Parmar
Mayur Parmar

Apremilast, Inderbir S. Padda, Rajat Bhatt, Mayur S. Parmar
Mayur Parmar

COVID (SARS-COV-2) Vaccine, Inderbir S. Padda, Mayur S. Parmar
Mayur Parmar

Pegloticase, Inderbir S. Padda, Rajat Bhatt, Mayur S. Parmar
Mayur Parmar

Lenvatinib, Inderbir S. Padda, Mayur S. Parmar
Mayur Parmar

Flucytosine, Inderbir S. Padda, Mayur S. Parmar
Mayur Parmar

Golimumab, Inderbir S. Padda, Rajat Bhatt, Mayur S. Parmar
Mayur Parmar

Tofacitinib, Inderbir S. Padda, Rajat Bhatt, Mayur S. Parmar
Mayur Parmar

Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors, Inderbir S. Padda, Arun U. Mahtani, Mayur S. Parmar
Mayur Parmar

Small Interfering RNA (siRNA)-Based Therapy, Inderbir S. Padda, Arun U. Mahtani, Mayur S. Parmar
Mayur Parmar

Upadacitinib, Inderbir S. Padda, Rajat Bhatt, Mayur S. Parmar
Mayur Parmar

Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors, Inderbir S. Padda, Arun U. Mahtani, Mayur S. Parmar
HPD Articles

Small Interfering RNA (siRNA)-Based Therapy, Inderbir S. Padda, Arun U. Mahtani, Mayur S. Parmar
HPD Articles

Golimumab, Inderbir S. Padda, Rajat Bhatt, Mayur S. Parmar
HPD Articles

COVID (SARS-COV-2) Vaccine, Inderbir S. Padda, Mayur S. Parmar
HPD Articles

Tofacitinib, Inderbir S. Padda, Rajat Bhatt, Mayur S. Parmar
HPD Articles

Upadacitinib, Inderbir S. Padda, Rajat Bhatt, Mayur S. Parmar
HPD Articles

Lenvatinib, Inderbir S. Padda, Mayur S. Parmar
HPD Articles

Pegloticase, Inderbir S. Padda, Rajat Bhatt, Mayur S. Parmar
HPD Articles

Apremilast, Inderbir S. Padda, Rajat Bhatt, Mayur S. Parmar
HPD Articles

Aducanumab, Inderbir S. Padda, Mayur S. Parmar
HPD Articles

Biosimilars Use in Medicine for Inflammatory Diseases, Inderbir S. Padda, Rajat Bhatt, Obaid Rehman, Mayur S. Parmar
HPD Articles

Flucytosine, Inderbir S. Padda, Mayur S. Parmar
HPD Articles